HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott S Zamvil Selected Research

Glatiramer Acetate (Copaxone)

1/2020Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS.
1/2019The Evolving Mechanisms of Action of Glatiramer Acetate.
12/2015Glatiramer acetate treatment negatively regulates type I interferon signaling.
5/2011Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.
11/2010Translational research in neurology and neuroscience 2010: multiple sclerosis.
3/2009Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis.
10/2008Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
10/2007Mechanism of action of glatiramer acetate in treatment of multiple sclerosis.
8/2007Type II monocytes modulate T cell-mediated central nervous system autoimmune disease.
7/2006How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott S Zamvil Research Topics

Disease

68Multiple Sclerosis
04/2022 - 09/2002
40Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 09/2002
15Autoimmune Diseases (Autoimmune Disease)
11/2020 - 11/2002
13Neuromyelitis Optica (Devic's Disease)
01/2020 - 11/2010
11Demyelinating Diseases (Demyelinating Disease)
01/2021 - 11/2002
9Paralysis (Palsy)
05/2017 - 11/2002
8Inflammation (Inflammations)
01/2021 - 04/2006
7Relapsing-Remitting Multiple Sclerosis
01/2019 - 09/2002
6Neuroinflammatory Diseases
04/2019 - 06/2003
5COVID-19
01/2022 - 01/2020
5Disease Progression
10/2016 - 09/2002
4Infections
10/2021 - 09/2003
4Neurodegenerative Diseases (Neurodegenerative Disease)
11/2018 - 06/2003
3Central Nervous System Diseases (CNS Diseases)
12/2019 - 06/2003
3Neoplasms (Cancer)
01/2018 - 01/2008
3Progressive Multifocal Leukoencephalopathy
08/2010 - 12/2008
2Atrophy
11/2019 - 05/2012
2Alzheimer Disease (Alzheimer's Disease)
11/2018 - 06/2003
2Chronic Progressive Multiple Sclerosis
01/2016 - 06/2004
2Encephalomyelitis (Myeloencephalitis)
09/2015 - 09/2002
2Atherosclerosis
09/2006 - 12/2005
1Hot Flashes
05/2022
1Thrombosis (Thrombus)
10/2021
1Thromboinflammation
10/2021
1Vasculitis (Vasculitides)
10/2020
1Encephalitis (Encephalitis, Rasmussen)
01/2020
1Glioma (Gliomas)
01/2020

Drug/Important Bio-Agent (IBA)

14Glatiramer Acetate (Copaxone)FDA Link
01/2020 - 09/2002
12Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2011 - 11/2002
11AntibodiesIBA
01/2021 - 12/2004
9AutoantigensIBA
01/2020 - 08/2007
7CytokinesIBA
01/2020 - 11/2002
7Natalizumab (Tysabri)FDA Link
01/2019 - 07/2006
7Pharmaceutical PreparationsIBA
12/2014 - 06/2004
6Immunoglobulin G (IgG)IBA
11/2021 - 11/2010
5AutoantibodiesIBA
10/2021 - 11/2010
5Proteins (Proteins, Gene)FDA Link
10/2021 - 12/2004
5Aquaporins (Water Channels)IBA
01/2018 - 11/2010
5Myelin-Oligodendrocyte GlycoproteinIBA
10/2016 - 05/2011
5Peptides (Polypeptides)IBA
04/2016 - 12/2004
4EpitopesIBA
10/2021 - 05/2017
4Immunoglobulins (Immunoglobulin)IBA
01/2020 - 07/2012
4InterferonsIBA
01/2020 - 11/2002
4laquinimodIBA
10/2016 - 01/2012
4Interferon-betaIBA
01/2005 - 09/2002
3Monoclonal AntibodiesIBA
10/2021 - 08/2010
3AntigensIBA
01/2020 - 08/2007
3Atorvastatin (Lipitor)FDA Link
02/2014 - 11/2002
3Immunosuppressive Agents (Immunosuppressants)IBA
02/2011 - 06/2004
3Biological ProductsIBA
10/2008 - 05/2006
3Mitoxantrone (Novantrone)FDA LinkGeneric
07/2006 - 06/2004
2Messenger RNA (mRNA)IBA
04/2022 - 11/2021
2COVID-19 VaccinesIBA
01/2022 - 09/2021
2Fibrinogen (Factor I)FDA Link
10/2021 - 09/2015
2FibrinIBA
10/2021 - 11/2018
2Alemtuzumab (Campath)FDA Link
11/2020 - 10/2020
2Rituximab (Mabthera)FDA Link
11/2020 - 08/2009
2Therapeutic UsesIBA
01/2020 - 08/2007
2ChemokinesIBA
01/2020 - 09/2015
2Oligoclonal BandsIBA
01/2020 - 12/2016
2Cholecalciferol (Vitamin D3)FDA Link
12/2019 - 01/2019
2Retinaldehyde (Retinal)IBA
11/2019 - 01/2017
2Interleukin-10 (Interleukin 10)IBA
04/2019 - 01/2019
2Immunoglobulin A (IgA)IBA
04/2019 - 01/2019
2Amino AcidsFDA Link
01/2019 - 08/2014
2ocrelizumabIBA
01/2018 - 01/2016
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
12/2016 - 08/2014
2EnzymesIBA
12/2016 - 02/2006
2Biomarkers (Surrogate Marker)IBA
09/2016 - 07/2013
2Dimethyl FumarateIBA
04/2016 - 06/2015
2Integrin alpha4beta1 (VLA-4)IBA
04/2016 - 05/2015
2peptide PIBA
08/2014 - 05/2013
2Immunomodulating AgentsIBA
02/2011 - 06/2004
2Neutralizing AntibodiesIBA
11/2007 - 12/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2007 - 11/2002
2Interleukin-12 (IL 12)IBA
08/2007 - 11/2002
2Simvastatin (Zocor)FDA LinkGeneric
01/2007 - 01/2005
2Coenzyme A (CoA)IBA
09/2006 - 12/2005
2Oxidoreductases (Dehydrogenase)IBA
09/2006 - 12/2005
2CholesterolIBA
09/2006 - 05/2006
1Hormones (Hormone)IBA
05/2022
1BNT162 VaccineIBA
04/2022
1VaccinesIBA
11/2021
1Indicators and Reagents (Reagents)IBA
11/2021
1SARS-CoV-2 spike proteinIBA
10/2021
1Blood Coagulation Factors (Coagulation Factor)IBA
10/2021
1B-Cell Maturation AntigenIBA
01/2021
1TACI receptor-IgG Fc fragment fusion proteinIBA
01/2021
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2021
1ozanimodIBA
01/2020
1anti-leucine-rich glioma-inactivated 1 autoantibodyIBA
01/2020
1acivicin (AT 125)IBA
01/2020
1Ataxin-1IBA
01/2020
1Leucovorin (Folinic Acid)FDA Link
01/2020
1Complement System Proteins (Complement)IBA
01/2020
1Glutamine (L-Glutamine)FDA Link
01/2020
1Glutathione (Reduced Glutathione)IBA
01/2020

Therapy/Procedure

36Therapeutics
05/2022 - 09/2002
4Immunotherapy
01/2022 - 11/2018
2Drug Therapy (Chemotherapy)
11/2010 - 09/2002